drugset / Trial / NCT02517697
Oral Nitrite Trial for Hypertension and Metabolic Syndrome
RandomizedParallel-groupTriple-blindTreatment
Summary
The objective of the study is to investigate effects of inorganic sodium nitrite on the cardiometabolic and hormonal disturbances observed in a targeted population of overweight/obese adults with metabolic syndrome and hypertension, at risk for insulin resistance and endothelial dysfunction.
Timeline
- Start
- 2020-10
- Primary completion
- 2021-04-13
- Completion
- 2021-04-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sodium Nitrite | Small molecule | 40 mg | Oral |